Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
30.62    -0.24 (-0.78%)
Bid:
30.62
Ask:
30.86
Spread: 0.24 (0.784%)
Market Cap: £485.89m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

AGM Trading Statement

Today 07:00

RNS Number : 4706J
THG PLC
24 June 2026
 

24 June 2026

 

THG PLC

 

AGM Trading Statement

 

 

 

H1 revenue growth of c.+6.5% (+7.6% excluding THG Nutrition Asia)

 

£94m Adjusted EBITDA up +36% YoY (LTM to May 2026), supporting strongest H1 free cash flow since 2021

 

Term Loan B trading above par in H1 2026, a record high

 

Full year guidance reiterated

 

 

THG PLC ("THG" or the "Group") provides the following update on trading ahead of its Annual General Meeting ("AGM") later today.

 

Figures and commentary reflect continuing CCY[1] unless otherwise stated.

 

 

Outlook and guidance

 

· Full year revenue, Adjusted EBITDA and cash expected to be in line with company consensus[2]. Guidance underpinned by H1 Group revenue growth of c.+6.5% (H1 2025: -2.5%) and H1 Adjusted EBITDA of at least £40m (c.+95% YoY adjusting for the sale of Claremont Ingredients which was sold in September 2025).

 

· H1 2026 free cash flow is expected to be the strongest since 2021.

 

· LTM Adjusted EBITDA of c.£94m to May 2026 (LTM to May 2025: £68.9m), driven by disciplined cost management, gross margin maintenance and targeted category expansion.

 

 

 

Matthew Moulding, CEO of THG, commented:

 

"We are on track with our growth and margin expansion strategy across the Group. By prioritising home markets and trending categories in THG Beauty, we continue to drive high-quality growth across an expanding customer base.

 

"In THG Nutrition, Myprotein is reaching more consumers than ever. Year-to-date unit growth of +60% has been underpinned by our rapid retail expansion and category diversification, with c.18% of D2C customers purchasing activewear in May 2026.

 

"The Group continues to deliver strong year-on-year Adjusted EBITDA growth, notwithstanding the broader macroeconomic backdrop, including unprecedented whey commodity inflation levels."

 

 

THG Beauty

 

· THG Beauty revenue growth was underpinned by a strong skincare performance (+9.2% YTD)[3]. Lookfantastic continues to outpace the UK prestige beauty market[4], supported by new brand launches including Dyson, BEAME and Dr. Loretta, alongside a growing active customer base.

 

· Campaign and ambassador activity remains a key engagement tool, with the Olivia Attwood launch delivering strong conversion and positive brand health momentum. Spontaneous awareness, prompted awareness and consideration are all up amongst the target audience[5], further positioning THG Beauty as the destination of choice for discovery across regime and trending brands. 

 

· Lookfantastic continues to demonstrate social commerce leadership as the #1 multi-brand beauty retailer on TikTok Shop, delivering YoY revenue growth of c.+48% in Q2.

 

 

THG Nutrition

 

· THG Nutrition sales growth continued across online and offline channels with an ongoing mix shift towards gross margin accretive products and categories helping to mitigate highly elevated whey input costs alongside strategic pricing.

 

· A focus on innovation across the portfolio during the first half has been a key growth driver, namely within the core powder range including the launch of the Impact Milkshake, blended range, the expansion of the MARS® partnership, and influencer led activewear collaborations supporting YoY AOV growth.

 

· The intentional pivot in Asia to license with pre-eminent local manufacturing and distribution partners remains on track (THG Nutrition revenue growth excluding Asia H1 2026: c.+11%), positioning the business for structurally higher-margin growth as the model scales.

 

· Licensed product sell-in is well on track to exceed 60m units during FY 2026 (FY 2025: 43m), led by the ready to drink category in UK retail. Myprotein will enter the energy, protein water, and breakfast categories, during H2 2026, further broadening its addressable market and share of convenience spend. 

 

· Myprotein reinforced its category leadership in B2B channels, outpacing the sports nutrition market by +50% and ranking as the number one clear whey brand with an 84% share of clear whey sales[6], whilst bars and snacks outpaced the total market by over 160bps[7].

 

· The customer base is growing and highly engaged, underpinned by record aided awareness, brand recognition and consideration[8], strengthening the foundation for future growth.

 

 

Term Loan B trading

 

· The Term Loan B is trading above par in H1 2026 for the first time since issuance in March 2025, reflecting lender confidence in the outlook following successive positive trading updates across 2025 and 2026.

 

THG Nutrition VAT update

 

As previously disclosed, THG has submitted retrospective VAT claims totalling c.£78m to HMRC in respect of certain protein powders and supplements, following the successful ruling in favour of Sun Warrior against HMRC. Earlier in the year, the Upper Tribunal dismissed HMRC's right to appeal. The Group, along with the wider nutrition industry, awaits a substantive response from HMRC, which has indicated it will provide in late Spring 2026, but this has not yet been received.

 

 

AGM results

 

Results from the AGM will be published later today via RNS as soon as practicable following the conclusion of the meeting.

 

For further information please contact:

 

Investor enquiries:

Jordan Foster, Deputy Chief Financial Officer

Investor.Relations@thg.com

 

Media enquiries:

Sodali & Co - Financial PR adviser

Tel: +44 (0) 20 7250 1446

Russ Lynch/Sam Austrums/Louisa Henry

thg@sodali.com

 

 

THG PLC

 

 

media-enquiries@thg.com

 

ENDS

 

Notes to editors

THG PLC is a global e-commerce group and brand owner headquartered in Manchester, UK, which operates through two leading consumer businesses: THG Beauty and THG Nutrition.

THG Beauty operates prominent online platforms including Lookfantastic, Dermstore and Cult Beauty, offering a valued route to market for over 1,000 third-party brands, alongside a specialist portfolio of owned brands.

THG Nutrition, led by Myprotein, the world's largest online sports nutrition brand, spans multiple health and wellness categories, delivering its products both directly to consumers and through strategic offline partnerships worldwide.

 

Cautionary Statement

Certain statements included within this announcement may constitute "forward-looking statements" in respect of the group's operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. No responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Company. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Statements in this announcement reflect the knowledge and information available at the time of its preparation.

 


[1] CCY defined as constant currency basis.

[2] Consensus dated 18/06/2026 and available at https://www.thg.com/investor-relations/analyst-consensus.

[3] YTD defined as 01/01/2026 - 31/05/2026.

[4] Circana Market Growth; Circana UK Total Market 04/01/2026 - 30/05/2026.

[5] YouGov Brand Tracking April 2026 vs April 2025.

[6] Nielsen Brand Tracking Retail Sales 12-week period up to 16 May 2026.

[7] Nielsen Brand Tracking Retail Sales 12-week period up to 16 May 2026.

[8] YouGov Brand Tracking April 2026 vs January 2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPURPQUPQPPW
Date   Source Headline
24th Jun 20267:00 amRNSAGM Trading Statement
12th Jun 20267:00 amRNS-R€445m Term Loan B trading above par at record high
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation
16th Apr 20254:45 pmRNSTR-1: Notification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.